IdentificationGeneric Name(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acidDrugBank Accession NumberDB07189BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid (DB07189)× CloseWeightAverage: 464.5119 Monoisotopic: 464.173607266 Chemical FormulaC29H24N2O4SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUDisintegrin and metalloproteinase domain-containing protein 17Not AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as phenylquinolines. These are heterocyclic compounds containing a quinoline moiety substituted with a phenyl group.KingdomOrganic compoundsSuper ClassOrganoheterocyclic compoundsClassQuinolines and derivativesSub ClassPhenylquinolinesDirect ParentPhenylquinolinesAlternative ParentsPhenylpyridines / Phenylpyrrolidines / Phenol ethers / Phenoxy compounds / Alkyl aryl ethers / Cyclopropanecarboxylic acids / Pyrrolidine-2-ones / Heteroaromatic compounds / Pyrroles / Lactams / Secondary carboxylic acid amides / Monocarboxylic acids and derivatives / Carboxylic acids / Azacyclic compounds / Organopnictogen compounds / Organonitrogen compounds / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds


 show 9 moreSubstituents2-phenylpyridine / 2-phenylpyrrolidine / 2-pyrrolidone / Alkyl aryl ether / Aromatic heteropolycyclic compound / Azacycle / Benzenoid / Carbonyl group / Carboxamide group / Carboxylic acid / Carboxylic acid derivative / Cyclopropanecarboxylic acid / Cyclopropanecarboxylic acid or derivatives / Ether / Heteroaromatic compound / Hydrocarbon derivative / Lactam / Monocarboxylic acid or derivatives / Monocyclic benzene moiety / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Phenol ether / Phenoxy compound / Phenylquinoline / Pyridine / Pyrrole / Pyrrolidine / Pyrrolidone / Secondary carboxylic acid amide


 show 23 moreMolecular FrameworkAromatic heteropolycyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyBFZXMIUWGSTUAL-ZSOKXDGFSA-NInChIInChI=1S/C29H24N2O4/c32-27(33)23-15-29(23)16-26(31-28(29)34)19-10-12-21(13-11-19)35-17-20-14-25(18-6-2-1-3-7-18)30-24-9-5-4-8-22(20)24/h1-14,23,26H,15-17H2,(H,31,34)(H,32,33)/t23-,26+,29-/m1/s1IUPAC Name(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acidSMILES[H][C@@]1(C[C@@]11C[C@]([H])(NC1=O)C1=CC=C(OCC2=CC(=NC3=C2C=CC=C3)C2=CC=CC=C2)C=C1)C(O)=OReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound25049750PubChem Substance99443660ChemSpider25056739ZINCZINC000040891582PDBe Ligand642PDB Entries3ewjClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.000513 mg/mLALOGPSlogP4.59ALOGPSlogP4.3ChemaxonlogS-6ALOGPSpKa (Strongest Acidic)4.09ChemaxonpKa (Strongest Basic)3.46ChemaxonPhysiological Charge-1ChemaxonHydrogen Acceptor Count5ChemaxonHydrogen Donor Count2ChemaxonPolar Surface Area88.52 Å2ChemaxonRotatable Bond Count6ChemaxonRefractivity129.82 m3·mol-1ChemaxonPolarizability50.58 Å3ChemaxonNumber of Rings6ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleYesChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.9508Blood Brain Barrier+0.8294Caco-2 permeable-0.7845P-glycoprotein substrateSubstrate0.637P-glycoprotein inhibitor INon-inhibitor0.9585P-glycoprotein inhibitor IINon-inhibitor0.7752Renal organic cation transporterNon-inhibitor0.8173CYP450 2C9 substrateNon-substrate0.8251CYP450 2D6 substrateNon-substrate0.782CYP450 3A4 substrateSubstrate0.5444CYP450 1A2 substrateNon-inhibitor0.5303CYP450 2C9 inhibitorNon-inhibitor0.602CYP450 2D6 inhibitorNon-inhibitor0.7299CYP450 2C19 inhibitorNon-inhibitor0.7582CYP450 3A4 inhibitorNon-inhibitor0.5542CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.6544Ames testNon AMES toxic0.7919CarcinogenicityNon-carcinogens0.9222BiodegradationNot ready biodegradable0.9921Rat acute toxicity2.6694 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9978hERG inhibition (predictor II)Non-inhibitor0.7502  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Disintegrin and metalloproteinase domain-containing protein 17KindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionZinc ion bindingSpecific FunctionCleaves the membrane-bound precursor of TNF-alpha to its mature soluble form. Responsible for the proteolytical release of soluble JAM3 from endothelial cells surface. Responsible for the proteolyt...Gene NameADAM17Uniprot IDP78536Uniprot NameDisintegrin and metalloproteinase domain-containing protein 17Molecular Weight93020.165 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:19 / Updated at June 12, 2020 16:52 